HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ari Voutilainen Selected Research
Ari Voutilainen Research Topics
Disease
4
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2021
3
Type 2 Diabetes Mellitus (MODY)
02/2024 - 01/2021
3
Neoplasms (Cancer)
01/2023 - 01/2022
3
Heart Diseases (Heart Disease)
07/2022 - 01/2019
3
Heart Failure
01/2022 - 01/2022
2
Prostatic Neoplasms (Prostate Cancer)
02/2023 - 07/2022
2
Venous Thromboembolism
01/2023 - 06/2019
2
Inflammation (Inflammations)
01/2022 - 01/2019
1
Gestational Diabetes (Gestational Diabetes Mellitus)
02/2024
1
Feeding and Eating Disorders (Eating Disorder)
02/2024
1
Atrial Fibrillation
10/2023
1
Vitamin D Deficiency
10/2023
1
Chronic Obstructive Pulmonary Disease (COPD)
02/2023
1
Hypotension (Low Blood Pressure)
01/2023
1
Pain (Aches)
01/2023
1
Chronic Renal Insufficiency
01/2023
1
Pneumonia (Pneumonitis)
10/2022
1
Prediabetic State (Prediabetes)
05/2022
1
Myocardial Ischemia (Ischemic Heart Diseases)
05/2022
1
Cognitive Dysfunction
01/2022
1
Chronic Disease (Chronic Diseases)
01/2022
1
Dementia (Dementias)
01/2022
1
Coronary Disease (Coronary Heart Disease)
01/2022
1
Renal Insufficiency (Renal Failure)
01/2021
1
Hemorrhage
01/2021
1
Constipation
01/2021
1
Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021
1
Wrist Fractures
01/2019
1
Alzheimer Disease (Alzheimer's Disease)
01/2017
1
Drug-Related Side Effects and Adverse Reactions
02/2015
Drug/Important Bio-Agent (IBA)
5
C-Reactive Protein
IBA
01/2023 - 01/2021
4
Vitamin D
FDA Link
Generic
10/2023 - 01/2022
4
Indicators and Reagents (Reagents)
IBA
01/2023 - 01/2022
4
Cholesterol
IBA
05/2022 - 01/2021
3
Cholecalciferol (Vitamin D3)
FDA Link
10/2023 - 01/2022
3
25-hydroxyvitamin D
IBA
02/2023 - 07/2022
3
Zinc
IBA
02/2023 - 01/2022
3
Copper
IBA
02/2023 - 01/2022
3
HDL Cholesterol
IBA
01/2023 - 01/2021
2
Lipids
IBA
01/2023 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2022
2
Antihypertensive Agents (Antihypertensives)
IBA
01/2023 - 01/2021
2
Oxygen (Dioxygen)
IBA
05/2022 - 01/2022
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2021 - 01/2021
1
Caffeine (No Doz)
FDA Link
Generic
02/2024
1
Insulin (Novolin)
FDA Link
02/2024
1
Coffee
FDA Link
02/2024
1
docosapentaenoic acid
IBA
01/2023
1
Albumins
IBA
01/2023
1
Docosahexaenoic Acids
IBA
01/2023
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
01/2023
1
Eicosapentaenoic Acid
IBA
01/2023
1
alpha-Linolenic Acid (Linolenic Acid)
IBA
01/2023
1
hydroxide ion
IBA
07/2022
1
Glucose (Dextrose)
FDA Link
Generic
05/2022
1
Sodium
IBA
01/2022
1
Apolipoproteins
IBA
01/2022
1
Cholinergic Antagonists (Anticholinergics)
IBA
01/2021
1
Lipoprotein(a)
IBA
06/2019
1
Serum Albumin
IBA
01/2019
1
Antidepressive Agents (Antidepressants)
IBA
01/2017
1
Benzodiazepines
IBA
01/2017
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2017
1
Potassium
IBA
02/2015
Therapy/Procedure
1
Therapeutics
01/2023
1
Pain Management
01/2023
1
Polypharmacy
02/2015
1
Length of Stay
02/2015